Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 201

    1.

    Role of metabolic syndrome components in HIV-associated sensory neuropathy.

    Ances BM, Vaida F, Rosario D, Marquie-Beck J, Ellis RJ, Simpson DM, Clifford DB, McArthur JC, Grant I, McCutchan JA; CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Metabolic Study Group.

    AIDS. 2009 Nov 13;23(17):2317-22.PMID: 19823068 [PubMed - in process]Related articles

    2.

    Management of HIV in resource limited settings.

    McCutchan JA.

    Curr Opin Infect Dis. 2009 Oct;22(5):464-70.PMID: 19730283 [PubMed - in process]Related articles

    3.

    Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.

    Ances BM, Sisti D, Vaida F, Liang CL, Leontiev O, Perthen JE, Buxton RB, Benson D, Smith DM, Little SJ, Richman DD, Moore DJ, Ellis RJ; HNRC group.

    Neurology. 2009 Sep 1;73(9):702-8.PMID: 19720977 [PubMed - indexed for MEDLINE]Related articles

    4.

    Role of metabolic syndrome components in human immunodeficiency virus-associated stroke.

    Ances BM, Bhatt A, Vaida F, Rosario D, Alexander T, Marquie-Beck J, Ellis RJ, Letendre S, Grant I, McCutchan JA.

    J Neurovirol. 2009 Jun 26:1-8. [Epub ahead of print]PMID: 19562611 [PubMed - as supplied by publisher]Related articles

    5.

    Psychiatric context of acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: IV.

    Atkinson JH, Higgins JA, Vigil O, Dubrow R, Remien RH, Steward WT, Casey CY, Sikkema KJ, Correale J, Ake C, McCutchan JA, Kerndt PR, Morin SF, Grant I.

    AIDS Behav. 2009 Dec;13(6):1061-7. Epub 2009 Jun 11.PMID: 19517225 [PubMed - in process]Related articles

    6.

    Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy.

    Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, Woods SP, McCutchan JA, Heaton RK, Ellis RJ.

    Neurology. 2009 Aug 4;73(5):342-8. Epub 2009 May 27.PMID: 19474412 [PubMed - indexed for MEDLINE]Related articles

    7.

    Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV.

    Bousman CA, Cherner M, Ake C, Letendre S, Atkinson JH, Patterson TL, Grant I, Everall IP; HNRC Group.

    J Affect Disord. 2009 Dec;119(1-3):84-91. Epub 2009 May 5.PMID: 19419773 [PubMed - in process]Related articles

    8.

    Neurologic complications of HIV disease and their treatment.

    Letendre SL, Ellis RJ, Everall I, Ances B, Bharti A, McCutchan JA.

    Top HIV Med. 2009 Apr-May;17(2):46-56. Review.PMID: 19401607 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals.

    Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, Frank LR, Grant I; Charter Group.

    J Neurovirol. 2009 Apr;15(2):187-95.PMID: 19306228 [PubMed - indexed for MEDLINE]Related articles

    10.

    Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.

    Achim CL, Adame A, Dumaop W, Everall IP, Masliah E; Neurobehavioral Research Center.

    J Neuroimmune Pharmacol. 2009 Jun;4(2):190-9. Epub 2009 Mar 17.PMID: 19288297 [PubMed - indexed for MEDLINE]Related articles

    11.

    Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution.

    Williams P, Wu J, Cohn S, Koletar S, McCutchan J, Murphy R, Currier J; AIDS Clinical Trials Group 362 Study Team.

    HIV Med. 2009 May;10(5):290-301. Epub 2009 Feb 8.PMID: 19220493 [PubMed - in process]Related articles

    12.

    Differential expression of immunophilins FKBP51 and FKBP52 in the frontal cortex of HIV-infected patients with major depressive disorder.

    Tatro ET, Everall IP, Masliah E, Hult BJ, Lucero G, Chana G, Soontornniyomkij V, Achim CL; HIV Neurobehavioral Research Center.

    J Neuroimmune Pharmacol. 2009 Jun;4(2):218-26. Epub 2009 Feb 6.PMID: 19199039 [PubMed - indexed for MEDLINE]Related articles

    13.

    Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection.

    Khanlou N, Moore DJ, Chana G, Cherner M, Lazzaretto D, Dawes S, Grant I, Masliah E, Everall IP; HNRC Group.

    J Neurovirol. 2009 Apr;15(2):131-8.PMID: 19115126 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations.

    Smith DM, Zárate S, Shao H, Pillai SK, Letendre SL, Wong JK, Richman DD, Frost SD, Ellis RJ; HNRC Group.

    Virology. 2009 Mar 1;385(1):204-8. Epub 2008 Dec 18.PMID: 19100592 [PubMed - indexed for MEDLINE]Related articles

    15.

    Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy.

    Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, McArthur JC, Simpson DM, Ake C, Collier AC, Gelman BB, McCutchan JA, Morgello S, Grant I; CHARTER Group.

    Ann Neurol. 2008 Nov;64(5):566-72.PMID: 19067367 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Low atazanavir concentrations in cerebrospinal fluid.

    Best BM, Letendre SL, Brigid E, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Ellis R, Capparelli EV, Grant I; CHARTER Group.

    AIDS. 2009 Jan 2;23(1):83-7.PMID: 19050389 [PubMed - indexed for MEDLINE]Related articles

    17.

    A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis.

    Huang J, Meixner L, Fernandez S, McCutchan JA.

    AIDS. 2009 Jan 2;23(1):51-7.PMID: 19050386 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection.

    Childers ME, Woods SP, Letendre S, McCutchan JA, Rosario D, Grant I, Mindt MR, Ellis RJ.

    J Neurovirol. 2008 Nov 18:1-8. [Epub ahead of print]PMID: 19016380 [PubMed - as supplied by publisher]Related articles

    19.

    Psychometric characteristics of the memory for intentions screening test.

    Woods SP, Moran LM, Dawson MS, Carey CL, Grant I; HIV Neurobehavioral Research Center (HNRC) Group.

    Clin Neuropsychol. 2008 Sep;22(5):864-78.PMID: 18756389 [PubMed - indexed for MEDLINE]Related articles

    20.

    Variable patterns of neuropsychological performance in HIV-1 infection.

    Dawes S, Suarez P, Casey CY, Cherner M, Marcotte TD, Letendre S, Grant I, Heaton RK; HNRC Group.

    J Clin Exp Neuropsychol. 2008 Aug;30(6):613-26. Epub 2008 Mar 4.PMID: 18608689 [PubMed - indexed for MEDLINE]Related articles

    21.

    Neurologic Complications of HIV Disease and Their Treatment.

    Letendre S, McCutchan JA, Ellis RJ.

    Top HIV Med. 2008 Mar-Apr;16(1):15-22.PMID: 18441379 [PubMed - in process]Related articlesFree article

    22.

    Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.

    Milefchik E, Leal MA, Haubrich R, Bozzette SA, Tilles JG, Leedom JM, McCutchan JA, Larsen RA.

    Med Mycol. 2008 Jun;46(4):393-5.PMID: 18415850 [PubMed - indexed for MEDLINE]Related articles

    23.

    Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management?

    Woods SP, Moran LM, Carey CL, Dawson MS, Iudicello JE, Gibson S, Grant I, Atkinson JH; HIV Neurobehavioral Research Center Group.

    Arch Clin Neuropsychol. 2008 May;23(3):257-70. Epub 2008 Feb 19.PMID: 18243645 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

    Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ; CHARTER Group.

    Arch Neurol. 2008 Jan;65(1):65-70.PMID: 18195140 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Two-year prospective study of major depressive disorder in HIV-infected men.

    Atkinson JH, Heaton RK, Patterson TL, Wolfson T, Deutsch R, Brown SJ, Summers J, Sciolla A, Gutierrez R, Ellis RJ, Abramson I, Hesselink JR, McCutchan JA, Grant I; HNRC Group.

    J Affect Disord. 2008 Jun;108(3):225-34. Epub 2007 Nov 28.PMID: 18045694 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Low CSF leptin levels are associated with worse learning and memory performance in HIV-infected men.

    Huang JS, Letendre S, Marquie-Beck J, Cherner M, McCutchan JA, Grant I, Ellis R.

    J Neuroimmune Pharmacol. 2007 Dec;2(4):352-8. Epub 2007 Oct 10.PMID: 18040853 [PubMed - indexed for MEDLINE]Related articles

    27.

    The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system.

    Letendre SL, Marquie-Beck J, Ellis RJ, Woods SP, Best B, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson D, Alexander TJ, Durelle J, Heaton R, Grant I; CHARTER Group.

    J Neuroimmune Pharmacol. 2007 Mar;2(1):120-7. Epub 2007 Jan 3.PMID: 18040835 [PubMed - indexed for MEDLINE]Related articles

    28.

    Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS.

    May S, Letendre S, Haubrich R, McCutchan JA, Heaton R, Capparelli E, Ellis R.

    J Neuroimmune Pharmacol. 2007 Mar;2(1):97-104. Epub 2007 Jan 10.PMID: 18040832 [PubMed - indexed for MEDLINE]Related articles

    29.

    Lopinavir with Ritonavir Reduces the HIV RNA Level in Cerebrospinal Fluid.

    Letendre SL, van den Brande G, Hermes A, Woods SP, Durelle J, Beck JM, McCutchan JA, Okamoto C, Ellis RJ; the HIV Neurobehavioral Research Center Group.

    Clin Infect Dis. 2007 Oct 19;45(11). [Epub ahead of print]PMID: 17952846 [PubMed - as supplied by publisher]Related articles

    30.

    A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients.

    Best BM, Goicoechea M, Witt MD, Miller L, Daar ES, Diamond C, Tilles JG, Kemper CA, Larsen R, Holland DT, Sun S, Jain S, Wagner G, Capparelli EV, McCutchan JA, Haubrich RH; California Collaborative Treatment Group 578 Study Team.

    J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):433-42.PMID: 17786128 [PubMed - indexed for MEDLINE]Related articles

    31.

    HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.

    McCutchan JA, Wu JW, Robertson K, Koletar SL, Ellis RJ, Cohn S, Taylor M, Woods S, Heaton R, Currier J, Williams PL.

    AIDS. 2007 May 31;21(9):1109-17.PMID: 17502721 [PubMed - indexed for MEDLINE]Related articles

    32.

    Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy.

    Monteiro de Almeida S, Letendre S, Zimmerman J, Kolakowski S, Lazzaretto D, McCutchan JA, Ellis R.

    J Neuroimmunol. 2006 Oct;179(1-2):180-5. Epub 2006 Aug 9.PMID: 16901548 [PubMed - indexed for MEDLINE]Related articles

    33.

    Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients.

    Langford D, Marquie-Beck J, de Almeida S, Lazzaretto D, Letendre S, Grant I, McCutchan JA, Masliah E, Ellis RJ.

    J Neurovirol. 2006 Apr;12(2):100-7.PMID: 16798671 [PubMed - indexed for MEDLINE]Related articles

    34.

    Genetic attributes of cerebrospinal fluid-derived HIV-1 env.

    Pillai SK, Pond SL, Liu Y, Good BM, Strain MC, Ellis RJ, Letendre S, Smith DM, Günthard HF, Grant I, Marcotte TD, McCutchan JA, Richman DD, Wong JK.

    Brain. 2006 Jul;129(Pt 7):1872-83. Epub 2006 May 30.PMID: 16735456 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Screening for major depression in persons with HIV infection: the concurrent predictive validity of the Profile of Mood States Depression-Dejection Scale.

    Patterson K, Young C, Woods SP, Vigil O, Grant I, Atkinson JH; HIV Neurobehavioral Research Center Group.

    Int J Methods Psychiatr Res. 2006 Jun;15(2):75-82.PMID: 19722288 [PubMed - indexed for MEDLINE]Related articles

    36.

    The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease.

    Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, Heaton RK, McCutchan JA, Grant I; HNRC Group.

    AIDS. 2005 Oct;19 Suppl 3:S72-8.PMID: 16251831 [PubMed - indexed for MEDLINE]Related articles

    37.

    Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors.

    Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez R, Brown GG, Ellis RJ, Letendre S, Videen JS, McCutchan JA, Patterson TL, Grant I; HNRC Group.

    J Neurovirol. 2005 Aug;11(4):356-64.PMID: 16206458 [PubMed - indexed for MEDLINE]Related articles

    38.

    Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults.

    Mathews WC, Caperna JC, Barber RE, Torriani FJ, Miller LG, May S, McCutchan JA.

    J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):155-60.PMID: 16186732 [PubMed - indexed for MEDLINE]Related articles

    39.

    Population pharmacokinetics of abacavir in plasma and cerebrospinal fluid.

    Capparelli EV, Letendre SL, Ellis RJ, Patel P, Holland D, McCutchan JA.

    Antimicrob Agents Chemother. 2005 Jun;49(6):2504-6.PMID: 15917556 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients.

    Diamond C, Richardson JL, Milam J, Stoyanoff S, McCutchan JA, Kemper C, Larsen RA, Hollander H, Weismuller P, Bolan R; California Collaborative Trials Group.

    J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):211-8.PMID: 15905739 [PubMed - indexed for MEDLINE]Related articles

    41.

    A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575.

    Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Tilles JG, Forthal DN, Leedom J, Leibowitz M, McCutchan JA, Richman DD; California Collaborative Treatment Group.

    AIDS. 2005 Feb 18;19(3):295-302.PMID: 15718840 [PubMed - indexed for MEDLINE]Related articles

    42.

    Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

    Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Günthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong JK.

    J Virol. 2005 Feb;79(3):1772-88.PMID: 15650202 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy.

    Koletar SL, Williams PL, Wu J, McCutchan JA, Cohn SE, Murphy RL, Lederman HM, Currier JS; AIDS Clinical Trials Group 362 Study Team.

    Clin Infect Dis. 2004 Nov 15;39(10):1500-6. Epub 2004 Oct 22.PMID: 15546087 [PubMed - indexed for MEDLINE]Related articles

    44.

    The correlation between plasma concentrations of protease inhibitors, medication adherence and virological outcome in HIV-infected patients.

    Yasuda JM, Miller C, Currier JS, Forthal DN, Kemper CA, Beall GN, Tilles JG, Capparelli EV, McCutchan JA, Haubrich RH; California Collaborative Treatment Group.

    Antivir Ther. 2004 Oct;9(5):753-61.PMID: 15535413 [PubMed - indexed for MEDLINE]Related articles

    45.

    Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders.

    Letendre SL, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, Heaton RK, Grant I, Ellis RJ; HNRC Group.

    Ann Neurol. 2004 Sep;56(3):416-23.PMID: 15349869 [PubMed - indexed for MEDLINE]Related articles

    46.

    Testicular pathologic changes and the pituitary-testicular axis during human immunodeficiency virus infection.

    Salehian B, Jacobson D, Swerdloff RS, Grafe MR, Sinha-Hikim I, McCutchan JA.

    Endocr Pract. 1999 Jan-Feb;5(1):1-9.PMID: 15251696 [PubMed]Related articles

    47.

    The relationship between AIDS retinal cotton wool spots and neuropsychological impairment in HIV-positive individuals in the pre-highly active antiretroviral therapy era.

    Freeman WR, McCutchan JA, Arevalo JF, Wolfson T, Marcotte TD, Heaton RK, Grant I; HNRC Group.

    Ocul Immunol Inflamm. 2004 Mar;12(1):25-33.PMID: 15209461 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    The impact of HIV-associated neuropsychological impairment on everyday functioning.

    Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I; HNRC Group.

    J Int Neuropsychol Soc. 2004 May;10(3):317-31.PMID: 15147590 [PubMed - indexed for MEDLINE]Related articles

    49.

    Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss.

    Archibald SL, Masliah E, Fennema-Notestine C, Marcotte TD, Ellis RJ, McCutchan JA, Heaton RK, Grant I, Mallory M, Miller A, Jernigan TL.

    Arch Neurol. 2004 Mar;61(3):369-76.PMID: 15023814 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Symptom-based framework for assessing quality of HIV care.

    Asch SM, Fremont AM, Turner BJ, Gifford A, McCutchan JA, Mathews WM, Bozzette SA, Shapiro MF.

    Int J Qual Health Care. 2004 Feb;16(1):41-50.PMID: 15020559 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...